Skip to main content

Find Clinical Trials

Home
Conditions
Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy

Clinical trial condition

Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy

Explore clinical trials studying Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy trial results

Not Yet Recruiting

A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model

NCT07239271

Conditions: Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy
Locations: Not specified

View Trial Details